Why JinkoSolar Shares Are Sliding Today
JinkoSolar Holding Co., Ltd (NYSE:JKS) reported a fourth-quarter FY22 revenue growth of 85.5% year-on-year to $4.41 billion, beating the consensus of…
Oracle, Buckle And 3 Stocks To Watch Heading Into Friday
With US futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Campbell Soup Gets Price Target Bumps By Analysts After Strong Q2 Results
Campbell Soup Co (NYSE: CPB) reported better-than-expected Q2 results and raised FY23 guidance.
Campbell reported quarterly sales growth of 12% year-on-year to $2.48 billion, beating the consensus of $2.44 billion. Adjusted EPS of $0.80 beat the analyst consensus of $0.74.
General Electric Stock Is Rising: What’s Driving The Action?
General Electric Co (NYSE: GE) shares are trading higher Thursday after the company updated guidance at its annual investor conference.
ANI Pharmaceuticals Sees FY23 Adjusted EPS of $2.09-$2.59 Vs. Consensus Of $2.62; Forecasts Revenues Of $360M-$385M Vs. $352.49M Estimate
2023 Cortrophin specific revenue guidance is between $80.0 million to $90.0 million, representing 92% to 116% growth as compared to $41.7 million recognized in
Asana CEO Plans To Purchase Up To 30M Stock Under Trading Plan, Shares Soar
On March 8, 2023, Asana, Inc (NYSE:ASAN) Chair and CEO Dustin Moskovitz shared plans to purchase up to 30 million…
Reported Late Wednesday March 08, ProMIS Neurosciences Announces FY22 Financial Results And Recent Highlights; Cash And Cash Equivalents Were $5.9M As Of December 31, 2022 Vs $16.9M YoY
Completed all preclinical studies and manufacturing to support PMN310 IND submission to U.S. Food and Drug Administration
Preclinical data that further characterize ongoing programs, including PMN310, to be presented